BioNxt Solutions Inc. (OTCMKTS:BNXTF) Sees Large Increase in Short Interest

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the target of a significant growth in short interest during the month of September. As of September 30th, there was short interest totalling 8,100 shares, a growth of 710.0% from the September 15th total of 1,000 shares. Based on an average daily trading volume, of 5,400 shares, the short-interest ratio is presently 1.5 days.

BioNxt Solutions Price Performance

OTCMKTS:BNXTF opened at $0.18 on Friday. BioNxt Solutions has a 12 month low of $0.00 and a 12 month high of $0.57. The firm’s 50 day moving average is $0.17 and its 200 day moving average is $0.23.

BioNxt Solutions (OTCMKTS:BNXTF) last announced its quarterly earnings results on Wednesday, August 28th. The company reported ($0.01) earnings per share (EPS) for the quarter.

BioNxt Solutions Company Profile

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.